| IPI00231331 - Map2k2, DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2. | |
|---|---|
| Uniprot Accession: P36506 | |
| Uniprot ID: MP2K2_RAT | |
| Mapping: Chr 7, 10074654 - 10094005 | |
| Entrez Gene: 58960 | |
| Entrez MapView: |
|
| RGD: 61888 | |
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_6761) |
|---|
| Rat: Map2k2, DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2. |
| Mouse: Map2k2, DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2. |
| Mouse: Map2k2, KINASE 2, FULL INSERT SEQUENCE. |
| Mouse: Map2k2, FULL INSERT SEQUENCE. |
| Mouse: Map2k2, MITOGEN ACTIVATED PROTEIN KINASE KINASE 2. |
| Rat: Map2k2, 27 KDA PROTEIN. |
| Human: MAP2K2, DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2. |
| Human: MAP2K2, 34 KDA PROTEIN. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| extracellular region | C | NAS | ||
| transferase activity | F | IEA | IEA | IEA |
| ATP binding | F | NAS IEA | IEA IEA | IEA |
| protein serine/threonine kinase activity | F | NAS IEA | IEA IEA | IEA |
| protein binding | F | IPI | ||
| kinase activity | F | IEA | ||
| protein-tyrosine kinase activity | F | IEA | IEA | IEA |
| protein kinase activity | F | IEA | ||
| nucleotide binding | F | IEA | IEA | IEA |
| protein amino acid phosphorylation | P | NAS IEA | IEA | IEA |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| skin/coat/nails phenotype | MP | Un | ||
| craniofacial phenotype | MP | Un | ||
| homeostasis/metabolism phenotype | MP | Un | ||
| lethality-embryonic/perinatal | MP | Un | ||
| vision/eye phenotype | MP | Un | ||
| digestive/alimentary phenotype | MP | Un | ||
| normal phenotype | MP | Un | ||
| hearing/vestibular/ear phenotype | MP | Un | ||
| growth/size phenotype | MP | Un |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| The extracellular signal-regulated RAF/MEK/ERK pathway | W | NASIMP |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Glioma (05214) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| GnRH signaling pathway (04912) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Long-term depression (04730) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Chronic myeloid leukemia (05220) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Toll-like receptor signaling pathway (04620) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Fc epsilon RI signaling pathway (04664) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| MAPK signaling pathway (04010) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| VEGF signaling pathway (04370) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Regulation of actin cytoskeleton (04810) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Gap junction (04540) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Insulin signaling pathway (04910) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Natural killer cell mediated cytotoxicity (04650) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Long-term potentiation (04720) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |